Angiomax
- Product NDC
- 0781-3447
- 11-digit product format
- 007813447
- Labeler code
- 0781
- Product ID
- 0781-3447_eddac8ab-ef06-4517-bbed-7ac30cc73df3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- bivalirudin
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- Sandoz Inc
- Application
- NDA020873
- Marketing category
- NDA
- Marketing start
- 2019-08-01
- Marketing end
- 0000-00-00
- Substance
- BIVALIRUDIN
- Active strength
- 250 mg/1
- Pharmacologic classes
- Anti-coagulant [EPC], Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0781-3447 | ANGIOMAX (BIVALIRUDIN) INJECTION [SANDOZ INC] | 2 | Legacy NDC | 20221130_5f133813-f74e-4508-bc64-debbf104ff1e.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0781-3447-95 | 00781344795 | 10 VIAL, SINGLE-USE in 1 CARTON (0781-3447-95) > 1 INJECTION in 1 VIAL, SINGLE-USE | 2019-08-01 | 0000-00-00 | No | No | Current |